English
Français
>>
>>
News
Agenda
Subscribe to news
The group
Profile/strategy
Onxeo corporate video
Key figures
Governance
Join us
Contact
our products
Development strategy
Our products
Partnerships
Investors
Key figures
The share price
Financial calendar
Financial information
Shareholders
General meetings
Regulated information
Media
Press Releases
Shareholder Letters
Videos
Press Review
Publications
Subscribe to news
Patients & Health care professionals
>
|
Média
|
Press Review
|
Onxeo Announces Final Data From Completed Phase II Trial Of Validive For The Prevention Of Severe Oral Mucositis In Head And Neck Cancer Patients
Onxeo Announces Final Data From Completed Phase II Trial Of Validive For The Prevention Of Severe Oral Mucositis In Head And Neck Cancer Patients
28 May, 2015
For more information: Biospace.com
